D. Western Therapeutics Institute Profit Margin

D. Western Therapeutics Institute posts a profit margin of -257.89% as of June 2026. That compares with -257.83% in the prior-year period — up 0.0% year over year. That is below the Healthcare sector average of 9.48%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, D. Western Therapeutics Institute's profit margin was -257.83%. The latest reading is -257.89% — essentially flat versus a year earlier (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 9.48% is typical. D. Western Therapeutics Institute's -257.89% is lower that level. That is roughly 2820.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

D. Western Therapeutics Institute's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -257.89% as of June 2026; use YoY and peer views to separate noise from signal.

Context for 4576.T's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 9.48%), and (3) consistency with growth and profitability. This page covers the first two; D. Western Therapeutics Institute's other metric pages and overview cover the third.